Teva Pharmaceutical Industries, Ltd.: all 671 studies
Page 5 of 7. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)CompletedNCT02674321Phase 1
- To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125CompletedNCT02673567Phase 1
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald ScalpCompletedNCT02611804Phase 3
- Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in AsthmaticsWithdrawnNCT02496715Phase 3
- Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and OlderCompletedNCT02437604Phase 1
- Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary DiseaseCompletedNCT02419872
- Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)TerminatedNCT02410356Phase 3
- Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD TreatmentCompletedNCT02384577
- Azilect® In Wearing-Off (AIWO)CompletedNCT02384512
- An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD PatientsTerminatedNCT02315144Phase 1
- Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017TerminatedNCT02315131Phase 1
- Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™Status unknownNCT02249663Phase 3
- Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy VolunteersCompletedNCT02215941Phase 1
- A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary DiseaseWithdrawnNCT02203474Phase 2
- Multiple Dose BE Study With Nevirapine 400mg PR TabletsCompletedNCT02202005Phase 1
- Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic MedicationCompletedNCT02184767Phase 1
- A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal WomenCompletedNCT02092571Phase 1
- A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient ChildrenTerminatedNCT02092077Phase 2
- A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given TogetherCompletedNCT02085863Phase 1
- A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced NeutropeniaCompletedNCT02044276Phase 3
- A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy AdultsCompletedNCT02030457Phase 1
- Safety and Bioavailability of IV and SC LBR-101CompletedNCT01991509Phase 1
- Absolute Bioavailability of Reslizumab in Healthy SubjectsCompletedNCT01990443Phase 1
- A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)WithdrawnNCT01975298Phase 3
- Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid TumorsWithdrawnNCT01940601Phase 2
- To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid TumorsCompletedNCT01922752Phase 1
- Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy SubjectsCompletedNCT01903824Phase 1
- Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent SubjectsCompletedNCT01887366Phase 2
- A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of RasagilineCompletedNCT01879748Phase 1
- An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine MepesuccinateCompletedNCT01844869Phase 1
- Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With AsthmaCompletedNCT01844401Phase 1
- Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone DeficiencyCompletedNCT01811576Phase 2
- The Nuvigil and Provigil Pregnancy RegistryTerminatedNCT01792583
- Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne VulgarisCompletedNCT01788384Phase 3
- To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01785433Phase 1/2
- A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release TabletCompletedNCT01769677Phase 1
- Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy SubjectsWithdrawnNCT01760980Phase 1
- A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release TabletCompletedNCT01758978Phase 1
- Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic RhinitisCompletedNCT01632540
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With NarcolepsyCompletedNCT01624480Phase 1
- A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid UsersCompletedNCT01596673Phase 1
- Adenovirus Vaccine Pregnancy RegistryWithdrawnNCT01584037
- Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung CancerWithdrawnNCT01563601Phase 3
- A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, AsthmaCompletedNCT01556607Phase 1
- Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With AnthracyclinesCompletedNCT01555944
- Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal AerosolCompletedNCT01537692Phase 1
- Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/ActuationCompletedNCT01523236Phase 1/2
- A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic KeratosesCompletedNCT01502020Not applicable
- A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne VulgarisCompletedNCT01501799Not applicable
- A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy VolunteersCompletedNCT01489306Phase 1
- Donepezil 10 mg Tablets Under Fed ConditionsCompletedNCT01439243Phase 1
- Donepezil 10 mg Tablets Under Fasting ConditionsCompletedNCT01439230Phase 1
- Open Label Extension Study to Protocol C2/13/DR-6MP-02WithdrawnNCT01433432Phase 2
- A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and TolerabilityWithdrawnNCT01404117Phase 2
- Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and TolerabilityCompletedNCT01400854
- Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy AdultsCompletedNCT01381796Phase 1
- A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy VolunteersCompletedNCT01355016Phase 1
- Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell LymphomaCompletedNCT01345357Phase 1
- A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic ImpairmentCompletedNCT01319279Phase 1
- A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal ImpairmentCompletedNCT01319266Phase 1
- A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)CompletedNCT01302587
- A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral ContraceptivesCompletedNCT01291004Phase 1
- Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and PlaceboCompletedNCT01257906Not applicable
- Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk HerniationCompletedNCT01240876Phase 1/2
- A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma SubjectsCompletedNCT01205737Phase 1
- Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)CompletedNCT01202786
- Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed ConditionsCompletedNCT01190761Phase 1
- Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting ConditionsCompletedNCT01190748Phase 1
- A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting ConditionsCompletedNCT01188057Phase 1
- A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting ConditionsCompletedNCT01188031Phase 1
- Bioequivalence of Adapalene Topical Gel in Patients With Acne VulgarisCompletedNCT01182636Phase 1
- Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal WomenTerminatedNCT01159873Phase 1
- Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting ConditionsCompletedNCT01149746Phase 1
- Valacyclovir 1000 mg Tablet Under Fasting ConditionsCompletedNCT01149499Phase 1
- Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical GelCompletedNCT01095640Not applicable
- Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's DiseaseTerminatedNCT01094613Phase 1/2
- Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in AdultsCompletedNCT01092351Phase 4
- A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)CompletedNCT01056159Phase 1
- Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting ConditionsTerminatedNCT01046214Phase 1
- Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's DiseaseCompletedNCT01032486
- Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent TherapyTerminatedNCT01023880Phase 1/2
- Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial VaginosisCompletedNCT01020396Phase 1/2
- Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT00982150Phase 2
- Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated MalariaCompletedNCT00978172Phase 4
- Divalproex Sodium 500 mg Extended Release Tablets Under Fasting ConditionsCompletedNCT00974441Phase 1
- Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting ConditionsCompletedNCT00974012Phase 1
- Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting ConditionsCompletedNCT00973050Phase 1
- Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed ConditionsCompletedNCT00972855Phase 1
- A Phase 1 Study to Investigate the Effects of Talampanel on the Heart RhythmCompletedNCT00964730Phase 1
- Azilect + Antidepressant Chart ReviewCompletedNCT00955604
- ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease SubjectsCompletedNCT00936676
- Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric PropertiesCompletedNCT00932581
- Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking MethotrexateTerminatedNCT00928317Phase 2
- Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid TumorsCompletedNCT00920595Phase 1
- Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed AdministrationCompletedNCT00889850Phase 1
- Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced CancerCompletedNCT00875264Phase 1
- A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed ConditionsCompletedNCT00871364Phase 1
- A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed ConditionsCompletedNCT00871247Phase 1
- A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed ConditionsCompletedNCT00870571Phase 1
- A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting ConditionsCompletedNCT00870480Phase 1
← Teva Pharmaceutical Industries, Ltd. overview and focus areas